Global Stock News

INmune Bio A No-Brainer Investment

Article feature image

INmune Bio A No-Brainer Investment

The Good Brigade/DigitalVision via Getty Images
INmune Bio’s September 2021 news for XPro
I am very bullish about INmune Bio (INMB). I first reported on INmune Bio in July 2021 in view of their upcoming Alzheimer’s disease (AD) readout with their drug…

Click here to view the original article.

Share this article

Scroll to Top